CorFlow Therapeutics AG raised €44 million in a Series B funding round co-led by Broadview Ventures and Panakes Partners to support the advancement of a novel diagnostic and drug delivery platform for microvascular obstruction in heart attack patients.
Amount Raised
€44 Million
Round Type
Series B
BaarBiotechnologyHealth CareMedicalMedical DeviceTherapeuticsInvestors
Description
CorFlow Therapeutics AG announced today that it has raised €44 million in Series B funding. This financing will support the MOCA II pivotal study intended to gain US market clearance for their CoFl system in diagnosing microvascular obstruction in heart attack patients.
Quick answer
CorFlow Therapeutics AG raised €44 Million in a Series B round, dated September 10, 2024. Investors: Monte Carlo Capital, KOFA Healthcare, Unorthodox Ventures, M&L Investments, Wellington Partners, Laerdal Million Lives Fund, Merieux Equity Partners and 415 Capital. CorFlow Therapeutics AG is based in Baar, Zug, Switzerland.
- How much did CorFlow Therapeutics AG raise?
- CorFlow Therapeutics AG raised €44 Million in a Series B round on September 10, 2024.
- Who invested in CorFlow Therapeutics AG?
- Monte Carlo Capital, KOFA Healthcare, Unorthodox Ventures, M&L Investments, Wellington Partners, Laerdal Million Lives Fund, Merieux Equity Partners and 415 Capital are named as investors in this round.
- What does CorFlow Therapeutics AG do?
- CorFlow Therapeutics AG is focused on developing innovative solutions for the diagnosis and treatment of microvascular obstruction in heart attack patients.
- Where is CorFlow Therapeutics AG based and how big is it?
- CorFlow Therapeutics AG is based in Baar, Zug, Switzerland. Fundz records about 11 employees.
- Who are the decision-makers at CorFlow Therapeutics AG?
- Fundz holds 2 contacts at CorFlow Therapeutics AG. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at CorFlow Therapeutics AG, and when
A new round usually means CorFlow Therapeutics AG is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CorFlow Therapeutics AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CorFlow Therapeutics AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CorFlow Therapeutics AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CorFlow Therapeutics AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCorFlow Therapeutics AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.